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Multinucleated giant cells were first  reported in tuberculous granulomas by Roki- 
tansky  (1)  and  Langhans  (2,  3)  over  a  century  ago.  These  giant  cells  are  now 
recognized as a common feature of granulomas induced both by immunological and 
nonimmunological stimuli (4, 5). Thus, they are found in granulomas associated with 
the immune response to tuberculosis, leprosy, syphilis, and various fungal and parasitic 
infections  as  well  as  in  granulomas associated with  nonimmuine responses  to  toxic 
agents such as silica,  beryllium, and asbestos, and to nontoxic agents such as carbon 
particles, plastic beads, and iron particles  (4). 
Nevertheless,  the  origin  and  the  mechanism  of the  formation  of multinucleated 
giant cells remain unclear. It is possible, because of the variety of agents that produce 
granulomas, that these cells  are formed by several different mechanisms. Thus, they 
may  arise  from  the  fusion  of nonreplicating  monocytes or  from  the  mitotic  and 
amitotic  division  of monocyte  nuclei  in  the  absence  of cellular  division.  Several 
observations suggest that cellular immune mechanisms play a  direct role.  The giant 
cells have been found in granulomas of the skin produced by delayed hypersensitivity 
reactions in humans and in experimental animals (6-8). Moreover, crude supernatants 
from cultures of antigen-stimulated lymph node cells  of rabbits have been shown to 
cause alveolar macrophages to form giant cells  in vitro (9,  10). 
In this paper we describe evidence that suggests that a heat-labile protein, ~60,000 
mol  wt,  released  from  antigen-  or  mitogen-stimulated  lymphocytes promotes  the 
formation of muhinucleated giant cells  from human monocyte precursors. Autoradi- 
ographic  studies  indicate  that  the  lymphocyte-derived giant  cell  protein  (GCP) 1 
induces giant cells by fusion of nonreplicating blood monocytes. 
* Supported in  part by grants AM16506, AM26034, and AI10085 from the  National Institutes of 
Health; funds from student research grant AM07405-01 from the U. S. Public Health Service; and research 
funds from the Veterans Administration. 
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i Abbreviations used m  this paper: GCF, giant cell factor; GCP, giant cell protein; [3H]TdR, tritiated 
thymidine; LPF, low power fields; MNL, mononuclear  leukocytes; PBS, 0.15 M NaCI/0.02 M phosphate, 
pH 7.4; PHA, phytohemagglutinin; NaIO4, sodium meta periodate; PPD, purified protein derivative of 
tuberculin; RPMI 1640 + PSH, RPMI 1640 medium containing penicillin (100 U/ml), streptomycin (100 
/.tg/ml), and Hepes buffer (0.001 M), pH 7.4; SBTI, soybean trypsin inhibitor. 
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Materials and Methods 
Giant  Cell Assay.  Peripheral  blood  mononuclear leukocytes  (MNL)  were  isolated  from 
venous blood of normal human donors by the Ficoll-Hypaque technique (11). Monocytes were 
purified from MNL by counter-flow centrifugation performed with a Beckman J-21C centrifuge 
equipped with the Elutriator Rotor and Sanderson separation chamber (Beckman Instruments, 
Inc., Spinco Div., Palo Alto, Calif.). Elutriation was performed by the procedure previously 
described by Sanderson et al. (12). After elutriation, monocytes were >95% pure as determined 
by morphology and positive staining for nonspecific esterases  (13). Viability was  >98%  as 
measured by trypan blue exclusion. 
Isolated monocytes were suspended at  a  density of  l0  s cells/ml in RPMI  1640 medium 
containing penicillin (100 U/ml), streptomycin (100 p,g/ml), and Hepes buffer (RPMI  1640 
+  PSH), and 30% AB+ human serum (heat inactivated, 56°C for 30 min). Aliquots (200 pl) 
were  dispensed into flat-bottomed wells of microtiter tissue  culture plates (Linbro Chemical 
Co., Hamden, Conn.). Culture supernatants or column fractions being tested for  giant cell- 
forming activity were added in volumes of 50/.tl to each well. 
After incubation, medium was aspirated from each well and plates were allowed to air dry. 
The cell layer in each well was stained with Wright's stain (Anderson Laboratories, Inc., Ft. 
Worth, Tex.), and the number of giant cells (cells containing two or more nuclei) in each well 
in a total of 10 low power fields (LPF X 200) was determined. Samples were tested in duplicate 
(column fractions) or quadruplicate. Results were  expressed  as the mean (duplicate determi- 
nations) or the mean _+ SEM (quadruplicate determinations). 
Leukocyte Cultures.  MNL were  isolated from venous blood of normal or tuberculin-positive 
donors by the Ficoll-Hypaque technique and suspended in serum-free RPMI  1640 +  PSH. 
Lymphocytes were purified by filtration of MNL through sterile columns packed with Sephadex 
G-10 (Pharmacia Fine Chemicals, Pharmacia Inc., Piscataway, N. J.)  as previously described 
(14, 15). The eluted population of cells contained <2% esterase-positive cells and >92% formed 
spontaneous rosettes  with sheep erythrocytes (16). 
Aliquots (2 ml) of MNL, purified lymphocytes, or purified monocytes at densities of 4 ×  l0  s 
cells/ml of serum-free RPMI  1640 +  PSH  were  dispensed into different Falcon 3033  tubes 
(Falcon Labware, Oxnard, Calif.) and cultured at 37°C in a humidified atmosphere containing 
5% CO2 for up to 72 h. Cultures were stimulated with tetanus toxoid 1:1,000 dilution (Eli Lilly 
and Co., Indianapolis, Ind.), purified protein derivative (PPD), 20 p,g/ml (Ministry of Agricul- 
ture, Fisheries  and Food, Surrey, England), phytohemagglutinin (PHA),  1 pg/ml (Burroughs 
Wellcome, Greenville, N. C.), or sodium meta periodate (NaIO4),  10  -3 M  for 30 min at 4°C 
(Sigma Chemical Co.,  St.  Louis,  Mo.).  Culture supernatants were  harvested at  appropriate 
times after cells were pelleted by centrifugation. Supernatants were stored at -70°C until they 
were tested for giant cell-forming activity. 
Lymphocyte  transformation was  measured  by culturing MNL  at  a  density of 2  ×  106 
cells/ml RPMI  1640 +  PSH containing 10% heat-inactivated AB+ serum with and without 
PPD or PHA. Four aliquots (200 pl) of each were placed in flat-bottomed wells of microtiter 
tissue culture plates. Cultures were pulsed at  114 h with 0.5/~Ci of tritiated thymidine ([3H] 
TdR, specific activity 1.9 Ci/mM, Schwarz/Mann, Div. Becton, Dickinson & Co., Orangeburg, 
N.  Y.) and harvested 6 h later. Cells from all microcultures were harvested onto Whatmann 
3MM paper filters (Arthur H. Thomas Co., Philadelphia, Pa.) with a multiple sample harvester 
(Brandel, Rockville, Md.). Filters containing harvested cells were placed in vials containing 5 
ml Aquasol (New England Nuclear, Boston, Mass.), and radioactivity was measured in a liquid 
scintillation counter. 
Gel Filtration Studies.  A column 2.5 cm Diam and 100 cm in length containing Sephadex G- 
100 was used to fraetionate supernatants from cultures of MNL. The column was run with 
0.015  M  glycylglycine/0.14 M  NaC1 at pH 7.2. Culture supernatants were concentrated 100- 
fold  by ultrafiltration in an Amicon chamber equipped with a  UM  2 membrane (Amicon 
Corp., Lexington, Mass.)  and cleared of insoluble material by centrifugation before they were 
applied to the column. 
Gel filtration was performed at 4°C. The column effluent was continuously monitored for 
absorbance at 280 nm with an ISCO model UA5 (Instrumentation Specialties Co., Lincoln, 
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tritiated water (New England Nuclear) was mixed with each sample before its application to 
the column to serve as an internal marker for column volume. 
Physicochemical Studies.  Heat  stability of Sephadex-purified  giant  cell-forming factor  was 
assessed  after  exposure  to  a  temperature  of 56°C  for  45  min. Serially diluted, heated,  and 
unheated factor were tested at the same time in the giant cell assay. 
Sephadex-purified giant cell-forming factor was incubated with trypsin (Sigma Chemical 
Co.)  at  37°C  for 4  h.  The reaction was stopped  by addition of a  fivefold excess of soybean 
trypsin inhibitor (SBTI, Sigma Chemical Co.). As a  control, the order of addition of trypsin 
and SBTI to the factor was reversed. Giant cell-forming activity in all samples was determined 
in the same assay. 
Autoradiography.  Autoradiographic studies  were  performed  with  [3H]TdR  in an effort  to 
determine  whether  giant  cells  were  forming by  fusion of nonreplicating monocytes  or  by 
repeated amitotic or mitotic nuclear division without cellular division of cytoplasm. Aliquots 
(500/~1) of elutriator-purified monocytes (105/ml) in RPMI  1640 +  PSH containing 30% AB+ 
serum were dispensed into wells of Falcon 3008 multiwell plates in which sterile glass cover slips 
had been previously placed.  [3H]TdR  (5 p,  Ci)  having a  specific activity of 1.9 Ci/mM and 
supernatant  from  culture of PHA-stimulated  MNL  (100  lal) were  added  to  each  well  and 
cultured  with  monocytes  for  7  d.  Cover  slips  containing the  monocyte  monolayers  were 
removed, washed extensively in 0.9% NaC1 solution, and then fixed with four 250-ml changes 
of 2% glutaraldehyde in 0.05 M  phosphate buffer, pH 6.8; one 250-ml wash of distilled water; 
and one 250-ml wash of 95% ethanol. The cover slips were air-dried and mounted on acid- 
cleaned slides with Pro-Texx (Lerner Laboratories, Stamford, Conn.). 
Autoradiography was performed as previously described by Boren et  al.  (17).  Slides were 
dipped in melted NTB2 nuclear tract emulsion (Eastman Kodak Co.) at 46°C, drained, cooled, 
and stored for 6 wk at 4°C in a taped box containing Drierite (W. A. Hammond Drierite Co., 
Zenia, Ohio). Exposed slides were developed in D-19 (Eastman Kodak Co.) at  15°C for 6 min 
and fixed with acid-hardened fixer for 10 min at  15°C. Fixer was removed with 20 changes of 
distilled water, and slides were stained with hematoxylin. 
Results 
Formation of Multinucleated Giant Cells.  MNL  from a  donor with immunity to tetanus 
toxoid  and  PPD  elaborated  a  soluble giant cell factor  (GCF)  when stimulated with 
these antigens or with the T  cell mitogen, NaIO4  (Fig.  1).  The giant cells contained 
discrete nuclei as illustrated in Fig. 2. In some experiments we have observed as many 
as  16 nuclei in a  single giant cell. The nuclei were unusually arranged  in a  random 
It 
0_ 
4C 
0 
~ 3c 
LEGEND 
(f)  []  Medio 
-~  2C  []  Tetonus Toxoid 
(~  •  PPD 
[] No  IO  4 
(-9 
0  ~  ~  Controls  24h  48h  72h 
Durotion  Of Lymphocyte Culture 
Flo.  l.  MNL were obtained from a donor with cell-mediated immunity to tetanus toxoid  and 
PPD (confirmed by positive lymphocyte transformation to these antigens). MNL were cultured 24, 
48, and 72 h with and without tetanus toxoid, PPD, and after treatment with NalO4 (see Materials 
and Methods). Aliquots (25 #1) of harvested MNL supernatant and mitogen control samples (RPMI 
1640 +  PSH to which tetanus toxoid or PPD were added)  were tested in the same experiment for 
their ability to induce giant cell formation.  LPF, low power fields. POSTLETHWAITE  ET  AL.  171 
Fio.  2.  Photomicrograph (×  1,000) of human blood monocytes  grown for 7 d in the presence of a 
1:6 dilution ofsupernatant from culture of MNL stimulated 72 h with PHA. One large muhinucle- 
ated giant cell is surrounded by single and binucleated monocytes. 
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Fro.  3.  MNL from a  normal  donor were cultured  for  72  h  with and  without  PHA.  PHA was 
added to supernatant  of the unstimulated MNL culture after harvest.  Aliquots (25 gl) of superna- 
tants  from  PHA-stimulated  (&)  or PHA-control (0)  cultures were added  to a series of wells of a 
microtiter plate  containing elutriator-purified  monocytes  (see Materials  and  Methods).  Culture 
medium  was  removed  from  each  of three  wells  containing  PHA-stimulated  and  PHA-control 
supernatant  1, 3, 5, 7, and 9 d after initiation of monocyte cultures.  The number of giant cells in 
each well was quantitated by microscopy. 
fashion  as  illustrated  in  Fig.  2,  but  on  rare  occasions  they  assumed  a  circular 
distribution  as in  Langhans'  type giant  cells. The  effect of time on  the generation  of 
giant  cells  by  the  factor  was  studied  by  exposing  monocytes  to  supernatants  from 
PHA-stimulated  or  unstimulated  cultures  of MNL.  Supernatant  from  PHA-stimu- 
lated  MNL  cultures  induced  formation  of significant  numbers  of giant  cells by  the 
third day ofmonocyte  culture  (Fig. 3). The number  of giant cells formed progressively 
increased throughout  9  d  of monocyte culture  (Fig. 3).  Only a  small number  of giant 
cells was  seen  in  day  9  monocyte  cultures  treated  with  supernatants  to  which  PHA 
was added  after harvesting from unstimulated  MNL  cultures  (Fig.  3). This probably 172  LYMPHOCYTE-MEDIATED  FUSION  OF  BLOOD  MONOCYTES 
represents spontaneous formation of giant cells; however, generation of the giant cell 
factor  by  PHA  stimulation  of  lymphocytes  contaminating  the  elutriator-purified 
monocytes cannot be excluded. 
The effect  of duration of monocyte exposure to the GCF on the number of nuclei 
present per giant cell was determined  by microscopic examination of the giant cells 
TABLE  I 
Effect of Duration of Monocyte Exposure to GCF on the Number of 
Nuclei per Giant Cell 
Percent giant cells containing indicated numbers of nuclei 
Duration of 
monocyte cul-  Nuclei per giant cell 
ture*  2  3  4  5  6  7  8  9  10 
d 
1  100  ........ 
3  83  9  6  1  --  I  --  --  -- 
5  62  17  12  4  5  .... 
7  46  22  1l  11  5  1  1  3  -- 
9  44  17  12  9  7  6  2  2  1 
* Microtiter plates  used  in  the  experiment described  in  the  legend  to  Fig.  3 
were  used  in  this study.  Giant  cells formed  in  wells containing elutriator- 
purified  monocytes cultured  for  1-9  d  with  aliquots of supernatant  from 
cultures of PHA-stimulated MNL  were examined microscopically, and  the 
number of nuclei  per giant cell was quantitated.  A  total of  100 giant cells 
were examined for each time period except for day-1  cultures. Only 25 giant 
cells were present in all three wells from day-I cultures. 
TABLE  II 
GCF Production and [3HI TdR Incorporation by Tuberculin-positive and -negative Subjects 
Subjects* 
Giant cells/10 LPF 
(mean +  SEM) 
['3H]TdR  incorporation  (mean +  SEM) 
Media  PHA  PPD  Media  PHA  PPD 
Tuberculin-poshive 
A  5--.  1  66±4  464.4  52±2  7,467±262  3,459 4-  106 
B  5+  1  44±5  454-6  217±48  6,724±288  6,232±  129 
C  4±  1  55±9  46±3  59±5  6,190±  199  3,539±  102 
D  4+  1  52±6  494.4  73+_4  9,100±231  2,726±  190 
E  7±  1  53+6  43±5  125±  14  9,160±843  5,523 4- 388 
Mean±SEM  5±  1  54±4  45±  1  105±30  7,728±607  4,2954.670 
Tuberculin-negative 
F  7+  1  77±3  4±  1  74+24  3,648+99  501±90 
G  5±  1  41  ±4  7±  1  92±6  6,621±  126  81±44 
H  3±  [  72±4  6±  1  32±  l  7,879+220  380±60 
I  5±2  30±4  5±3  442±21  18,873±660  1,3904.  158 
MeaniSEM  54.  1  55±  11  6±  1  160±94  9,255+-3326  5884.281 
* Peripheral  blood  MNL  were  obtained  from  tuberculin-positive  or  tuberculin-negative  subjects  and 
cultured as described in  Materials and  Methods  in serum-free  RPMI  1640  for  72  h  with and without 
PPD (20 #g/ml) or PHA  (1 #g/ml). Culture supernatants were tested for their ability to cause formation 
of giant cells. Media alone and to which PPD or PHA were added induced formation of 6 +  1, 4 +  1, and 
6 +  1 giant cells per 10 LPF, respectively. [3H]TdR incorporation was measured as described in Materials 
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Ft~.  4.  MNL from the same donor described in Fig.  1 were passed over Sephadex G-10 columns 
to  remove  monocytes and  other  adherent  cells  (see  Materials and  Methods).  The  eluted  cells 
contained <2% esterase-positive mononuclear cells, and 93% formed spontaneous rosettes with sheep 
erythrocytes. This enriched T  lymphocyte population was cultured for 24, 48, and 72 h with and 
without tetanus toxoid, PPD, and PHA, and a portion was treated with NalO4 (see Materials and 
Methods). Aliquots (25/zl) of harvested cuhure supernatants and control samples (RPMI  1640 + 
PSH to which tetanus toxoid, PPD, or PHA were added) were tested in the same assay for GCF 
activity. 
TABLE  III 
Inability of Monocytes to Produce GCF* 
Duration of  Giant cells/10 LPF  culture 
h 
Monocytes+media  Monocytes+PHA 
24  3±2  3±1 
48  4±2  3±1 
72  2±1  4±1 
MNL +  media  MNL +  PHA 
72  6±2  68±7 
Media  Media +  PHA 
4-1-1  3±2 
* MNL and monocytes (>95% esterase positive) purified by centrifugal elu- 
triation were cultured in serum-free RPMI  1640 +  PSH for up to 72 h with 
and without PHA (1 /~g/ml)  as described in Materials and Methods. Har- 
vested supernatants were diluted 50% with serum-free RPMI  1640 +  PSH 
and tested for their ability to induce giant cell formation. 
formed  in  wells  containing  elutriator-purified  monocytes  cultured  for  1-9  d  with 
aliquots of supernatants  from culture of PHA-stimulated  MNL  (Table I). Giant  cells 
formed  by monocytes exposed  to the GCF  for 24 h  contained  only two nuclei per cell 
(Table  I).  Exposure  of monocytes  to  the GCF  for 3-9  d  resulted in the formation  of 
giant cells containing  from 2  to  10 nuclei (Table I). These data suggest that giant cells 
containing  many  nuclei  per  cell  tend  to  arise  in  monocyte  cultures  exposed  to  the 
GCF  for long periods of time (i.e.,  5-9 d). 
GCF Production  by  Tuberculin-positive  and  Tuberculin-negative  Subjects.  MNL  from  tu- 
berculin-positive  and  tuberculin-negative  donors  were  cultured  with  PPD  to  deter- 
mine  whether  production  of the  GCF  by  antigen-stimulated  MNL  correlated  with 174  LYMPHOCYTE-MEDIATED  FUSION  OF  BLOOD  MONOCYTES 
T 
0 
8 0.7  ~ 
0.6 
~05. 
0.4. 
0.3 
02 
Ol 
0 
08 
07 
06 
05. 
04. 
0.3. 
02 
OI 
C  - 
0.8 
3O 
25 
t '° 
"0  ~" 
35  2 
3O  0 
~-25  r- 
• 
03  4  05  .  .  ~.,.~a  v.~ 
V E /  VT~ 
FIo.  5.  MNL  (8  ×  10  s)  from a  normal donor were divided into two equal aliquots. One aliquot 
was treated with NaIO4 and the other with 0.15 M  NaCI/0.02  M  phosphate (PBS)  as described in 
Materials and Methods. NaIO4-treated and PBS-treated MNL were cultured at a density of 4  ×  106 
cells/ml of serum-free  RPMI  1640  +  PSH  for  72  h.  Harvested supernatant  (100  ml)  from  each 
culture was concentrated by ultrafiltration to a  volume of 3 ml and subjected to gel filtration on the 
same column of Sephadex G-100  (see Materials and Methods).  Aliquots (50/~1)  from each column 
run were tested in the same assay for GCF activity. 
TABLE IV 
Heat Stability Studies 
Giant cells/ 
Condition*  Dilutions 
10 LPF 
GCF untreated  Undiluted  47 +  5 
1:2  51  ±  2 
1:4  42 ±  4 
1:8  23 +  2 
GCF +  56°C  (45 min)  Undiluted  7 ±  1 
1:2  8±  1 
1:4  5±  1 
1:8  9±  1 
Buffer  3  ±  1 
* GCF  purified by gel  filtration of supernatant  from  PHA-stimulated  MNL 
was serially diluted and aliquots of each dilution were heated to 56°C for 45 
min. Heated and unheated samples of GCF were tested in the same assay for 
their ability to induce giant cell formation. 
the  presence  of delayed  hypersensitivity  to  antigen.  The  degree  of cell-mediated 
immunity in the donor to PPD was assayed by lymphocyte transformation (Table II). 
PPD-stimulated  MNL  from tuberculin-positive donors all  produced GCF, whereas 
those from tuberculin-negative donors did not  (Table II). Similar amounts of GCF 
were  produced  by  PHA-stimulated  MNL  both  from  tuberculin-positive and  from 
tuberculin-negative donors  (Table II). Thus, the production of GCF in response to 
antigen may be an in vitro correlate of cell-mediated immunity. 
Production of GCF by Monocyte-depleted Lymphocytes.  It was of interest to determine 
whether peripheral blood lymphocytes enriched in T  cells and depleted of monocytes 
by passage through Sephadex G-10 columns could produce the GCF when stimulated 
by antigens  or  mitogens.  Monocyte-depleted lymphocytes from  a  tuberculin-  and 
tetanus toxoid-immune donor elaborated the GCF when stimulated by these antigens POSTLETHWAITE ET AL.  175 
TABLE V 
T~ypsin Sensitivity Studies 
Added after incuba-  Condition*  tion  Giant cells/10 LPF 
Buffer + HBSS$  HBSS  3 ±  1 
GCF + HBSS  HBSS  51 ± 2 
GCF + trypsin  SBTI  2 ±  1 
GCF + SBTI  Trypsin  40 ± 3 
* GCF (200 p,l) purified by gel filtration of supernatant from PHA-stimulated 
MNL was incubated at 37°C with trypsin (12.5 btg in 25/~1 HBSS) for 4 h, 
and the reaction was stopped by addition of a 5-times excess of SBTI. As a 
control, the order of addition of trypsin and SBTI to GCF was reversed. 
:[: Hanks' balanced salt solution. 
or  by  PHA  or  NaIO4  (Fig.  4).  In  contrast,  PHA-stimulated  monocytes  were  not 
capable of generating the GCF  (Table  III). These data support  the conclusion that 
GCF is of T  cell origin and that it is not a  monokine. 
Gel Filtration Studies.  In an effort to determine the approximate  molecular weight 
of the  giant  cell  factor,  supernatants  from  cultures  of NaIO4-treated  MNL  were 
pooled and fractionated on a column packed with Sephadex G-100, Column fractions 
were tested  for their  ability to induce  the  formation of giant  cells.  A  single peak of 
giant  cell-forming activity eluted  from the column  after the excluded  proteins  (Fig. 
5).  As determined  by gel filtration,  the GCF was found to be -60,000  mol wt. As a 
control,  supernatant  from  0.15  M  NaCI/0.02  M  phosphate,  pH  7.4  (PBS)-treated 
MNL from the same donor was fractionated on the same column of Sephadex G-100, 
and column fractions were tested  for giant cell-forming activity. Gel filtration of the 
control supernatant  did  not yield active fractions  (Fig.  4).  In additional  studies,  we 
found that GCF produced by streptokinase-streptodornase-  or PHA-stimulated MNL 
also has a  molecular weight of -60,000  (data not shown). 
Physicochemical Characterization of Partially  Purified  GCF.  Physicochemical  studies 
were  performed  on  partially  purified  giant  cell  factor isolated  by Sephadex  G-100 
chromatography.  It  was  found to be heat  labile,  because  its  biological activity was 
destroyed after incubation at 56°C for 45 min  (Table IV). Its biological activity also 
was destroyed by proteolytic digestion  with  trypsin  (Table V).  Taken  together,  our 
data indicate that the GCF is a  heat-labile protein of-60,000 mol wt. 
Autoradiographic Studies.  Monocytes were cultured  for 7 d  with supernatants  from 
PHA-stimulated  MNL to induce the formation of giant cells.  [3H]TdR was added at 
the beginning to the monocyte cultures to label newly synthesized DNA. Autoradiog- 
raphy was then performed on the monocyte monolayers. After 6 wk exposure, stained 
monolayers  overlayed  with  emulsion  were  examined  under  the  light  microscope. 
Microscopic fields  (X  1,000)  were selected  at  random until  a  total of 500 cells were 
counted. Uptake of [3H]TdR into nuclear DNA was observed in 4 of 377 mononuclear 
cells.  123 multinucleated  giant cells were examined.  In  120 giant cells, no detectable 
[3H]TdR  was  incorporated  into  nuclear  DNA.  In  the  remaining  three  giant  cells, 
[3H]TdR was incorporated into only one nucleus of each cell. 
These autoradiographic  data suggest that  lymphocyte-derived GCP promotes the 
formation  of muhinucleated  giant  cells  by facilitating  the  fusion  of nonreplicating 176  LYMPHOCYTE-MEDIATED  FUSION  OF  BLOOD  MONOCYTES 
monocytes rather  than  by  inducing  repeated  amitotic  or  mitotic  nuclear  division 
without cellular division of monocyte cytoplasm. 
Discussion 
A quantitative in vitro assay that measures the formation of multinucleated giant 
cells from precursor human peripheral blood monocytes is deseribed.  By using this 
assay, we have found that human peripheral blood lymphocytes, when stimulated by 
T  cell mitogens or antigens, produce a soluble factor that causes monocytes to form 
multinucleated giant cells. 
The production by lymphocytes of giant cell factor in the presence of PPD in vitro 
correlated with delayed hypersensitivity to this antigen in vivo. Monocyte-depleted 
lymphocytes were shown  to elaborate GCF  when  they were cultured with specific 
antigen or mitogen, suggesting that there is little or no requirement for monocytes for 
the production of the GCF. Physicochemical studies indicated that this GCF is a heat- 
labile protein of ~60,000 mol wt. Our autoradiographic studies suggest that the GCP 
promotes the formation of giant cells by fusing nonreplicating monocytes. 
Earlier studies  in the rabbit  have demonstrated that  alveolar macrophages from 
normal  animals  form multinucleated giant  cells in  vitro when  they are exposed to 
supernatants  of lymphocyte cultures rich in lymphokines (9,  10).  Our  finding that 
human  peripheral  blood monocytes under  the  influence of a  soluble  lymphocyte- 
derived factor fuse and form multinucleated giant cells suggests that multinucleated 
giant cells present in cell-mediated immune granulomas in different body tissues and 
organs could develop from circulating monocytes. We have previously demonstrated 
in  the  guinea  pig  that  at  least  three  lymphokines  (lymphocyte mitogenic  factor, 
lymphocyte-derived chemotactic  factor for monocytes, and  macrophage  migration 
inhibitory factor) are released in vivo at sites of cell-mediated immune reactions (18- 
20).  These  studies  could  provide  a  basis  for  postulating  that  in  man,  circulating 
monocytes might accumulate in granulomas at sites of  cell-mediated immune reactions 
by chemotactic migration in response to lymphocyte-derived chemotactic factor for 
monocytes. Macrophage migration inhibitory factor could act to retain monocytes at 
the granuloma site. Lymphocyte-derived GCF then could cause accumulated mono- 
cytes to fuse and form multinucleated giant cells. 
The morphology of the multinucleated giant cells formed in vitro after exposure of 
blood monocytes to the lymphocyte-derived factor is generally different from that of 
the  classic  giant  cells  of  the  Langhans'  type  found  in  vivo  at  sites  of  delayed 
hypersensitivity reactions. The reason for this discrepancy is not apparent from our 
study,  although  Langhans'  type giant  cells are  usually  associated  with  removal of 
necrotic tissue (4). It is possible that factors released from necrotic tissue or from other 
sources cause the nuclei of the Langhans' giant cells to assume a peripheral location. 
The functions of multinucleated giant cells in granulomas remain to be clarified. 
Our study demonstrates the feasibility of inducing the formation of multinucleated 
giant cells in vitro from precursor human blood monocytes. These observations may 
facilitate future studies of the biological features and functions of human multinucle- 
ated giant cells. 
Summary 
Multinucleated giant  cells are associated with granulomas arising from immuno- 
logical and nonimmunological inflammatory reactions. They are an integral part of POSTLETHWAITE ET AL.  177 
the host immune response to chronic infectious diseases.  In the present study we have 
demonstrated that human lymphocytes when stimulated by specific antigens or T cell 
mitogens produce a soluble factor that causes peripheral blood monocytes to fuse and 
form multinucleated giant cells in vitro. Production of the giant cell factor by antigen- 
stimulated peripheral blood lymphocytes correlates with the existence of  cell-mediated 
immunity to specific antigen. Monocyte-depleted blood lymphocytes, but not purified 
blood monocytes, produce the giant cell factor when cultured with antigens or T  cell 
mitogens. Gel  filtration  and  physicochemical studies  indicate  that  the  lymphocyte- 
derived giant cell  factor is a  heat-labile  protein of ~60,000 tool wt.  These  findings 
suggest  that  multinucleated  giant  cells  in  granulomas may be  formed by fusion of 
circulating  monocytes in  response  to  the  release  of a  60,000-mol  wt  protein  from 
antigen-stimulated T  lymphocytes. 
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